With an estimated 23% of the UK population classed as obese, the country has the second highest rate of obesity in Europe. However, obesity is just the tip of the iceberg as treatment can be dispensed to those who classed as overweight with a BMI of over 26 for some products, and over 26 with co-morbidities for others (please refer to product SPCs).
The provision of NHS weight loss treatments is restrictive. A private service offers access for many patients who have failed on weight loss treatments previously or want access to licensed medicines not available on the NHS. PharmaDoctor offer orlistat, Mysimba® and Saxenda® as options. With Mysimba® not being available on the NHS, and with the NHS offering limited access to Saxenda® at the time of writing. Those interested in delivering a service including Mysimba® and Saxenda® require training by PharmaDoctor's specialist trainer (please contact the switchboard for information).